knee degenerative joint disease.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: those aged 18-80 weight between 50-120 kg ability to read, write and complete informed consent
Exclusion criteria
Exclusion criteria: drug sensitivity drug dependence neurologic disease psychiatric illness cardiac disease liver disease cardiac arrythmia Diabetes neuromuscular problem inflammatory arthritis e.g. RA renal disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Amount of post operative morphin sulfate injection after the total knee arthroplasty. Timepoint: during 72 hr after the total knee arthroplasty. Method of measurement: mg morphin injected by the nursery and documented in the patien's documents. | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual analogue scale. Timepoint: during 72 h postoperatively 1 week and 1 months after surgery. Method of measurement: 1 to 10 based on the VAS scale.;WOMAC. Timepoint: 1 DAY before OR, 1 week and 1 month after OR. Method of measurement: womac scale.;KSS. Timepoint: 1 DAY before OR, 1 week and 1 month after OR. Method of measurement: KSS scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Tehran University of Medical Sciences